How HRS-1893 moves through the body in healthy men
Part of Heart & circulation clinical trials.
This study looks at how a single dose of an investigational drug called HRS-1893 is processed and removed from the body in healthy men. You'll stay at the clinic and provide blood and urine samples for several days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man between 18 and 45 years old.
- Your weight is at least 110 lbs (50 kg) and your BMI is between 19 and 26.
- You have no major health issues based on blood tests, urine tests, heart tests, and imaging.
- You have not taken any medications (prescription or over-the-counter) in the past month.
- You don't smoke more than 5 cigarettes a day, don't drink heavily, and don't use drugs.
- You agree to avoid certain foods and drinks (like grapefruit, caffeine, alcohol) during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a tiny amount of radioactive tracer in an injection to see how the drug moves through the body and leaves it. It is only for healthy men between 18 and 45.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This study tests how a healthy male body absorbs, uses, and removes a new experimental medication. Researchers track the drug's path through your body using a special radioactive marker to understand how it works and ensure it's safe.
This trial tests a new drug called HRS-1893 for people with heart failure with preserved ejection fraction (HFpEF). It aims to see if the drug can improve symptoms and quality of life.
This trial tests how a new drug called RNK08954 is processed by the body after food, and how it is eliminated. It is for healthy adults who want to help researchers understand the drug's safety and effects.
This study tracks how a new experimental drug (HRS-1780) moves through and leaves your body. Researchers will give you a single dose and measure where it goes and how it's eliminated, which helps them understand if it's safe for future patients.
Hear when a new Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.